* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. For research purposes only.
Paradigm Peptides is permanently closed. Owner Matthew Kawa of Illinois pleaded guilty to federal charges on December 10, 2025, and was sentenced on July 30, 2026 to 70 months in prison, with a $5 million money judgment against him and $78,317.52 in restitution owed jointly and severally with his co-defendant, per the U.S. Department of Justice. The Paradigm Peptides website is dead as of August 24, 2026, and no relaunch has appeared.
Of all the vendor exits between mid-2025 and mid-2026, this is the biggest cautionary tale in the record — the one that ended in prison sentences rather than a closure notice.
What happened to Paradigm Peptides?
Paradigm Peptides ended in a federal criminal case, not a quiet shutdown notice. According to the Department of Justice case record, owner Matthew Kawa and his sister, Jennifer Stechkober of Indiana, pleaded guilty in federal court on December 10, 2025; Kawa was sentenced on July 30, 2026 to 70 months in prison, and Stechkober received 16 months.
The DOJ's account of the case describes the sale of unapproved drugs with intent to defraud and illegal importation of product from China and India. CBS News's coverage of the court filings reports forged laboratory certificates, and per court records, some products sold as SARMs actually contained testosterone. Prosecutors placed the customer base at roughly 54,000 people across all 50 states and 80 countries.
What was the sentence in the Paradigm Peptides case?
Matthew Kawa was sentenced on July 30, 2026 to 70 months in federal prison, with a $5 million money judgment against him and $78,317.52 in restitution owed jointly and severally with his co-defendant; Jennifer Stechkober was sentenced to 16 months, per the DOJ sentencing release and CBS News coverage of the hearing.
At sentencing, the judge described the operation as leaving "an incredible trail of harm." That characterization is the court's, quoted from the proceeding.
Is the Paradigm Peptides website still up?
No. As of August 24, 2026 the Paradigm Peptides domain returns an error rather than a storefront, a closure notice, or any customer guidance, and no relaunch has appeared.
Can customers with pending orders get money back?
The DOJ record describes court-ordered restitution, not a vendor refund process, and the site went dark without posting refund or pending-order guidance. Facts only, no legal advice:
The July 30, 2026 sentencing included $78,317.52 in court-ordered restitution, owed jointly and severally by the two defendants; the DOJ release is the authoritative source on how restitution in the case is handled.
Standard card-network dispute processes exist independently of any vendor; eligibility windows and timelines are set by the card issuer, not by the merchant.
What does the case mean for stranded researchers?
Strip the case to its documented elements — forged laboratory certificates, per court coverage of the filings, and mislabeled compounds, per court records — and the research-side lesson is specific: the paperwork is only worth what independently verifies it. A certificate a vendor prints for itself proved, in this case, to be forgeable at scale. The checks that catch that are structural: third-party testing by a named lab, batch-level traceability, and identity confirmation that goes beyond a label.
Evo Amino is a US-based supplier of research-grade peptides, third-party tested and HPLC verified, with a third-party Certificate of Analysis per batch. Browse the full catalog, and see our Paradigm Peptides alternative guide for the replacement-supplier evaluation in full.
For the sourced editorial timeline of the case, Amino Axiom maintains a deep-dive at aminoaxiom.com/vendor-status/paradigm-peptides. Disclosure: Amino Axiom is part of the same brand network as Evo Amino, and this article recommends our own store.
For research use only. Not for human use. All compounds sold by Evo Amino are intended exclusively as laboratory research materials. Evo Amino makes no claims regarding the therapeutic, diagnostic, or medicinal use of any product. Purchasers must confirm they are 21 years of age or older and that all materials will be used in accordance with applicable research regulations.
Reference
Common questions
Paradigm Peptides ended in a federal criminal case. Owner Matthew Kawa pleaded guilty on December 10, 2025 and was sentenced on July 30, 2026 to 70 months in prison, per the U.S. Department of Justice.
Matthew Kawa was sentenced on July 30, 2026 to 70 months in federal prison, with a $5 million money judgment against him and $78,317.52 in restitution owed jointly and severally with his co-defendant; Jennifer Stechkober was sentenced to 16 months, per the DOJ release.
No. As of August 2026 the Paradigm Peptides domain returns an error rather than a storefront, a closure notice, or any customer guidance, and no relaunch has appeared.
Stay in the loop
New compounds, research updates & exclusive subscriber deals.
